Guidelines and Tools

In this section, this SWG wants to provide a broad list of practical recommendations for the diagnosis and management of AML. This list will be updated on a regular basis.

1) European LeukemiaNet recommendation for the management of AML in adults (2017): https://ashpublications.org/blood/article-pdf/129/4/424/1402046/blood733196.pdf

2) European LeukemiaNet recommendation for the management of APL (2019): https://ashpublications.org/blood/article-pdf/133/15/1630/1553020/blood894980.pdf

3) European Society for Medical Oncology guidelines for the management of AML in adults (2020): https://www.annalsofoncology.org/article/S0923-7534(20)36079-8/pdf

4) British Society of Haematology guidelines for the management of AML in pregnancy (2015): https://onlinelibrary.wiley.com/doi/epdf/10.1111/bjh.13554

5) American Society of Hematology guidelines for the management of AML in older adults (2020): https://ashpublications.org/bloodadvances/article-pdf/4/15/3528/1751528/advancesadv2020001920c.pdf

6) National Comprehensive Cancer Network guidelines for the management of AML and APL (2021) (requires free registration): https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf

7) European LeukemiaNet recommendation for minimal residual disease monitoring in AML (2021): https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2021013626/1832241/blood.2021013626.pdf

8) Annual clinical updates on AML; American Journal of Hematology by Elihu Estey (2021): https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.25975